Dr. Allison Leigh Tsao, MD

Dr. Tsao practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Tsao's NPI, 1689906372, was assigned on February 4, 2010. Dr. Tsao graduated from Johns Hopkins University School of Medicine in 2011. Dr. Tsao holds Massachusetts license 272009.

Dr. Tsao's primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Tsao's primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Tsao is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Tsao to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tsao practices, 2 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Tsao's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dmand AI has Dr. Tsao's licenses on file in 3 states: Massachusetts, Maryland and Pennsylvania.

CMS data shows 359 Medicare services from Dr. Tsao across 10 procedure codes in 2024, for 165 Medicare patients. Medicare paid $27,611 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Dr. Tsao in 2024. The largest group is 65 to 74, with 68 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 21% are also on Medicaid. Their average risk score is 2.52, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tsao's median patient age at 58, with 45% women.

In 2024, Dr. Tsao wrote 55 Medicare Part D claims for 20 patients. 89% of them were for generic drugs. CMS names the drug for 24 of them, across 2 drugs with 11 or more claims each, at $168 in total drug cost. In 2019, CMS named 47 claims across 2 drugs.

Dr. Tsao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of coronary angioplasty and stenting by Dr. Tsao, more than 50% of the clinicians it reports for that procedure.

CMS Open Payments shows 60 general payments to Dr. Tsao from 14 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 54% of the total. Edwards Lifesciences Corporation paid the most, $6,350. It also lists 1 research payment totaling $1,605 in 2020.

Dr. Tsao graduated from Johns Hopkins University School of Medicine in 2011.